Skip to main content
Scheduling

Virtual visit appointments available 7 days a week from 9:00am to 11:00pm. Learn More

COVID-19 Updates

COVID-19 Updates: Get the latest on vaccine information, in-person appointments, virtual visits and more. Learn More

Location

Texas Medical Center

Specialty
Cancer and Hematology
Phone: Clinic: 832-822-4242
Fax: 832-825-1453
Office Phone
832-824-4681
Email

pabaxter@texaschildrens.org

Address

Office: 1102 Bates Ave., Ste. 1590
Houston, TX 77030

Patricia A. Baxter, MD, MBA

Director, Clinical Research Operations, Cancer and Hematology Center
Associate Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine

Education

School Education Degree Year
Baylor College of Medicine Masters Master of Science, Clinical Investigation, Clinical Scientist Training Program 2012
Baylor College of Medicine Fellowship Pediatric Hematology-Oncology 2009
Rice University, Jones Graduate School of Business University Master of Business Administration 2009
A.I. DuPont Hospital for Children Residency Pediatrics 2006
Jefferson Medical College Medical School Doctor of Medicine 2002

About

Dr. Patricia Baxter's area of interest and expertise is in pediatric neuro-oncology, developmental therapeutics and palliative care. She completed her pediatric hematology-oncology fellowship training at Texas Children’s Hospital in 2009.

Dr. Baxter has extensive experience in the areas of clinical pharmacology and clinical trial design. As the Associate Director of Clinical Research Operations at one of the largest pediatric cancer centers in the country, she provides clinical research education to faculty, nurses and research staff, reviews new protocols for feasibility, and implements processes in order to maintain the highest quality of data.

In addition, she is board certified in Clinical Pharmacology, and obtained a Master’s of Science degree in clinical research from Baylor College of Medicine.

Her training on the K12 faculty training grant and research experiences have been enriched by the incredible mentorship of both Drs. Susan Blaney and Stacey Berg, two of the national leaders in developmental therapeutics. This mentorship was been vital in the development of PBTC-033, a phase I/II study evaluating Veliparib in combination with radiation and temozolomide in the treatment of patients with DIPG.

Her expertise in clinical trial design and conduct was recognized by the Pediatric Brain Tumor Consortium and resulted in her appointment to leadership positions, including: the Chair of the New Agent Committee where she works to identify new agents for evaluation and develop study concepts, membership on the Toxicity and Monitoring Committee and the Quality Assurance Committee, as well as appointment to the National Institutes of Health (NIH) Brain Malignancy Steering Committee as a Pediatric Brain Tumor Consortium (PBTC) representative.

Her career goal is to improve the prognosis and quality of life of patients with brain tumors. The training and mentorship she has received through the K12, her experiences as a cooperative group study chair, her expertise in clinical research operations and her participation in clinical research quality oversight have allowed her to develop expertise as a clinical researcher. 

Dr. Patricia Baxter's interests are in pre-clinical and clinical research studies of new therapies for patients with brain tumors.

Clinical Interests

  • Pediatric brain tumors
  • Pediatric solid tumors

Research Interests

  • Pre-clinical and clinical research studies of new therapies for patients with brain tumors

Organizations

Organization Name Role
American Society of Clinical Oncology (ASCO) Member
Children's Oncology Group (COG) Member

Research Statement

Dr. Patricia Baxter's research focus has been on examining the role of BMI-1 in pediatric brain tumors. 

Her fellowship research training was conducted in the laboratory of former faculty member, Xiao-Nan Li, MD PhD, where she utilized his orthotopic xenograft CNS models for pre-clinical screening of novel therapeutics agents. She continued to work closely with Xiao-Nan and this collaboration has been extremely helpful in bridging basic brain tumor biology and the clinic. The lab serves as the core lab for preclinical testing for the Pediatric Pre-Clinical Testing Consortium, which allows her team to generate the necessary pre-clinical data to quickly move forward to the clinic

Awards & Honors

2022    Star Faculty Award for Excellence in Clinical Care, Baylor College of Medicine
2019    RRO Quarterly Clinical Research Award, Texas Children’s Hospital
2015    BCM Department of Pediatrics Education Pilot Award
2014    BCM Department of Pediatrics Education Pilot Award
2013    Pediatric Oncology Research Faculty Training Program, NIH K-12 Award
2012    Pediatric Oncology Research Faculty Training Program, NIH K-12 Award
2011    Pediatric Oncology Research Faculty Training Program, NIH K-12 Award
2010    Pediatric Oncology Research Faculty Training Program, NIH K-12 Award
2010    Hyundai Hope on Wheels Scholar
2010    Pediatric Oncology Fellowship Research Training Program, NIH T-32 Award
2009    Hyundai Hope on Wheels Scholar
2009    Pediatric Oncology Fellowship Research Training Program, NIH T-32 Award
2009    ASCO Young Investigator Award
2009    Award for Presentation of Research, Texas Children’s Hospital Cancer Center Symposium
2008    Bone Marrow Transplant Oral Presentation Award, Center for Cell and Gene Therapy
2008    Tumor Board Presentation Award, Texas Children’s Cancer Center
2008    Chief Fellow, Pediatric Hematology-Oncology, Baylor College of Medicine
2008    Pediatric Oncology Fellowship Research Training Program, NIH T-32 Award
2008    Pediatric Research Training Program, NIH T-32 Award
2007    Pediatric Research Training Program, NIH T-32 Award
2007    Pediatric Research Training Program, NIH T-32 Award
2005    Chief Fellow, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
2005    Senior Resident Teaching Award

Board Certification

American Board of Clinical Pharmacology, ​​​​​​​American Board of Pediatrics, ​​​​​​​American Board of Pediatrics - Palliative Care and Hospice Medicine, ​​​​​​​American Board of Pediatrics - Pediatric Hematology-Oncology

Language

English



* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.